Abstract
The latest treatment guidelines for heart failure, created and endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA) and the International Society for Heart and Lung Transplantation, recommend an ultrafiltration-based therapy developed by CHF Solutions Inc, a privately owned manufacturer of medical devices for cardiac care, based in Brooklyn Park, Minnesota, USA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
